Virbac, one of the world’s leading companies in animal health, is continuing its expansion in Europe.
In addition to the recent finalization of the creation of its Irish subsidiary, Virbac announces the acquisition of its historical distributor in the Czech Republic and Slovakia, which becomes its 35th subsidiary.
This development strategy strengthens the group’s position in the European market for animal health.
Present in the Czech Republic and Slovakia since 2000 through its historical distributor, Virbac is well aware of these two markets, mainly oriented towards pets and ruminants.
In order to continue the development of its activities in this region and strengthen its presence in Central Europe, Virbac has acquired GS Partners, one of its oldest distributors in this area. This acquisition crowns the excellent work done for years by the teams of Jakub Satrapa, its former owner and future CEO of the Virbac subsidiary.
The new Virbac subsidiary in Ireland and the acquisition of GS Partners in the Czech Republic and Slovakia will allow the group to respond more broadly and quickly to the health needs of animals in these countries. Therefore, this development strategy strengthens Virbac’s position in the European animal health market, where the group continues to grow and expand.
Healthtech & Biotech News – Nice Côte d’Azur France
- ExactCure Towards a Strategic Rapprochement with Quantum Genomics
- Microalgae: €2M Fundraising for Inalve
- Business Landing Nice Côte d’Azur: Support for business set up in France
- Animal Health: Affaire de Santé PetCare Establishes Presence in Nice
- Nice University Hospital: New Recognition for its Excellence in Research and Innovation
- ExAdEx-Innov and EXSYMOL Monaco: A Collaboration at the Heart of Cosmetic Innovation
- Virbac will enhance its presence in the Indian animal health market
- University of Côte d’Azur and CHU of Nice at the forefront of research on healthy aging
- Nice Côte d’Azur Metropolis Acceleration Program: 12 winning companies.
- Virbac celebrates 30 years in the Asia-Pacific region and announces its consolidated revenue for Q2 2023